Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jan 15;313(Pt 2):555–560. doi: 10.1042/bj3130555

Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

D Belorgey 1, S Dirrig 1, M Amouric 1, C Figarella 1, J G Bieth 1
PMCID: PMC1216943  PMID: 8573092

Abstract

The kinetic investigation of the inhibition of human pancreatic trypsin 1, trypsin 2 and chymotrypsin A by mucus proteinase inhibitor, eglin c and aprotinin reveals that (i) the first protein is a potent inhibitor of chymotrypsin A (kass. = 1.4 x 10(6) M-1.s-1, Ki = 71 pM) but forms loose complexes with trypsin 1 (Ki = 0.5 microM) and trypsin 2 (Ki = 18 nM), (ii) eglin c does not inhibit the two trypsins but forms a tight complex with chymotrypsin A (kass. = 3.3 x 10(6) M-1.s-1, Ki < 0.1 nM) and (iii) aprotinin is a potent inhibitor of trypsin 1 (kass. = 1 x 10(6) M-1.s-1, Ki < 0.2 nM) and trypsin 2 (kass. = 2.4 x 10(5) M-1.s-1, Ki < 1 nM) but forms a loose complex with chymotrypsin A (Ki = 0.17 microM). These data, together with those published previously on human pancreatic elastase, suggest that a cocktail of aprotinin + eglin c might be a better intensive-care drug for acute pancreatitis than aprotinin alone, because it will efficiently inhibit all four human pancreatic proteinases. On the other hand, human gastric juice inactivates mucus proteinase inhibitor by pepsin-mediated cleavage. This indicates that the fraction of mucus proteinase inhibitor that reaches the stomach following aerosol delivery to cystic fibrosis patients does not reach the duodenum in an active form and, therefore, does not aggravate the pancreatic insufficiency of these patients.

Full Text

The Full Text of this article is available as a PDF (392.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armand M., Hamosh M., DiPalma J. S., Gallagher J., Benjamin S. B., Philpott J. R., Lairon D., Hamosh P. Dietary fat modulates gastric lipase activity in healthy humans. Am J Clin Nutr. 1995 Jul;62(1):74–80. doi: 10.1093/ajcn/62.1.74. [DOI] [PubMed] [Google Scholar]
  2. Aubry M., Bieth J. A kinetic study of the inhibition of human and bovine trypsins and chymotrypsins by the inter-alpha-inhibitor from human plasma. Biochim Biophys Acta. 1976 Jun 7;438(1):221–230. doi: 10.1016/0005-2744(76)90238-2. [DOI] [PubMed] [Google Scholar]
  3. BERNARD A., PAGET M., LAMELIN P. [Trypsinogen-trypsin and its inhibitors in acute pancreatitis]. Arch Mal Appar Dig Mal Nutr. 1960 May;49:632–643. [PubMed] [Google Scholar]
  4. Baici A., Seemüller U. Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis. Biochem J. 1984 Mar 15;218(3):829–833. doi: 10.1042/bj2180829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bieth J. G. In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem Med. 1984 Dec;32(3):387–397. doi: 10.1016/0006-2944(84)90046-2. [DOI] [PubMed] [Google Scholar]
  6. Boudier C., Bieth J. G. Mucus proteinase inhibitor: a fast-acting inhibitor of leucocyte elastase. Biochim Biophys Acta. 1989 Mar 16;995(1):36–41. doi: 10.1016/0167-4838(89)90230-6. [DOI] [PubMed] [Google Scholar]
  7. Boudier C., Carvallo D., Roitsch C., Bieth J. G., Courtney M. Purification and characterization of human bronchial proteinase inhibitor. Arch Biochem Biophys. 1987 Mar;253(2):439–445. doi: 10.1016/0003-9861(87)90197-4. [DOI] [PubMed] [Google Scholar]
  8. Braun N. J., Bodmer J. L., Virca G. D., Metz-Virca G., Maschler R., Bieth J. G., Schnebli H. P. Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G. Biol Chem Hoppe Seyler. 1987 Apr;368(4):299–308. doi: 10.1515/bchm3.1987.368.1.299. [DOI] [PubMed] [Google Scholar]
  9. Cadène M., Boudier C., de Marcillac G. D., Bieth J. G. Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor. J Biol Chem. 1995 Jun 2;270(22):13204–13209. doi: 10.1074/jbc.270.22.13204. [DOI] [PubMed] [Google Scholar]
  10. De Caro A., Figarella C., Guy O. The two human chymotrypsinogens. Purification and characterization. Biochim Biophys Acta. 1975 Feb 27;379(2):431–443. doi: 10.1016/0005-2795(75)90150-6. [DOI] [PubMed] [Google Scholar]
  11. Faller B., Bieth J. G. Kinetics of the interaction of chymotrypsin with eglin c. Biochem J. 1991 Nov 15;280(Pt 1):27–32. doi: 10.1042/bj2800027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Faller B., Dirrig S., Rabaud M., Bieth J. G. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin. Biochem J. 1990 Sep 15;270(3):639–644. doi: 10.1042/bj2700639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Figarella C., Negri G. A., Guy O. The two human trypsinogens. Inhibition spectra of the two human trypsins derived from their purified zymogens. Eur J Biochem. 1975 May 6;53(2):457–463. doi: 10.1111/j.1432-1033.1975.tb04086.x. [DOI] [PubMed] [Google Scholar]
  14. Guy O., Lombardo D., Bartelt D. C., Amic J., Figarella C. Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry. 1978 May 2;17(9):1669–1675. doi: 10.1021/bi00602a014. [DOI] [PubMed] [Google Scholar]
  15. Hochstrasser K., Reichert R., Schwarz S., Werle E. isolierung und Charakterisierung eines Proteaseninhibitors aus menschlichen Bronchialsekret. Hoppe Seylers Z Physiol Chem. 1972 Feb;353(2):221–226. [PubMed] [Google Scholar]
  16. Largman C., Brodrick J. W., Geokas M. C. Purification and characterization of two human pancreatic elastases. Biochemistry. 1976 Jun 1;15(11):2491–2500. doi: 10.1021/bi00656a036. [DOI] [PubMed] [Google Scholar]
  17. Lasson A. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment. Scand J Gastroenterol Suppl. 1984;99:1–57. [PubMed] [Google Scholar]
  18. Laurent P., Rabaud M., Bieth J. G. Inhibition of free and elastin-bound human pancreatic elastase by human bronchial inhibitor. Biochem Pharmacol. 1987 Mar 1;36(5):765–767. doi: 10.1016/0006-2952(87)90731-3. [DOI] [PubMed] [Google Scholar]
  19. Lenarcic B., Kos J., Dolenc I., Lucovnik P., Krizaj I., Turk V. Cathepsin D inactivates cysteine proteinase inhibitors, cystatins. Biochem Biophys Res Commun. 1988 Jul 29;154(2):765–772. doi: 10.1016/0006-291x(88)90206-9. [DOI] [PubMed] [Google Scholar]
  20. Lenarcic B., Krasovec M., Ritonja A., Olafsson I., Turk V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett. 1991 Mar 25;280(2):211–215. doi: 10.1016/0014-5793(91)80295-e. [DOI] [PubMed] [Google Scholar]
  21. McElvaney N. G., Doujaiji B., Moan M. J., Burnham M. R., Wu M. C., Crystal R. G. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1056–1060. doi: 10.1164/ajrccm/148.4_Pt_1.1056. [DOI] [PubMed] [Google Scholar]
  22. McElvaney N. G., Nakamura H., Birrer P., Hébert C. A., Wong W. L., Alphonso M., Baker J. B., Catalano M. A., Crystal R. G. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest. 1992 Oct;90(4):1296–1301. doi: 10.1172/JCI115994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miller K. W., Evans R. J., Eisenberg S. P., Thompson R. C. Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli. J Bacteriol. 1989 Apr;171(4):2166–2172. doi: 10.1128/jb.171.4.2166-2172.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ohlsson K., Olsson A. S. Purification and partial characterization of human pancreatic elastase. Hoppe Seylers Z Physiol Chem. 1976 Aug;357(8):1153–1161. doi: 10.1515/bchm2.1976.357.2.1153. [DOI] [PubMed] [Google Scholar]
  25. Ohlsson K., Tegner H. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest. 1976 Sep;36(5):437–445. doi: 10.3109/00365517609054461. [DOI] [PubMed] [Google Scholar]
  26. Rink H., Liersch M., Sieber P., Meyer F. A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli. Nucleic Acids Res. 1984 Aug 24;12(16):6369–6387. doi: 10.1093/nar/12.16.6369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rudolphus A., Kramps J. A., Dijkman J. H. Effect of human antileucoprotease on experimental emphysema. Eur Respir J. 1991 Jan;4(1):31–39. [PubMed] [Google Scholar]
  28. Seemüller U., Arnhold M., Fritz H., Wiedenmann K., Machleidt W., Heinzel R., Appelhans H., Gassen H. G., Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Lett. 1986 Apr 7;199(1):43–48. doi: 10.1016/0014-5793(86)81220-0. [DOI] [PubMed] [Google Scholar]
  29. Seemüller U., Meier M., Ohlsson K., Müller H. P., Fritz H. Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe Seylers Z Physiol Chem. 1977 Sep;358(9):1105–1107. doi: 10.1515/bchm2.1977.358.2.1105. [DOI] [PubMed] [Google Scholar]
  30. Smith C. E., Johnson D. A. Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases. Biochem J. 1985 Jan 15;225(2):463–472. doi: 10.1042/bj2250463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Thompson R. C., Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6692–6696. doi: 10.1073/pnas.83.18.6692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tsushima H., Mine H., Kawakami Y., Hyodoh F., Ueki A. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology. 1994 Jan;140(Pt 1):167–171. doi: 10.1099/13500872-140-1-167. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES